CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.89
+0.02 (+1.07%)
Open$1.93
Previous Close$1.87
Day High$2.09
Day Low$1.89
52W High$7.91
52W Low$0.97
Volume—
Avg Volume14.8K
Market Cap5.59M
P/E Ratio—
EPS$-2.92
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,647.6% upside
Current
$1.89
$1.89
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K |
| Net Income | -10,980,221 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -10,846,157 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |